Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 13/20 | 0.48 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | CA4 | P22748 | 4/20 | 0.47 |
| ▸ | CA7 | P43166 | 4/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6886720 | 0.85 | PTGS2 (0.64) | PTGS2PTGS1 | |
| SCHEMBL5201916 | 0.85 | PTGS2 (0.64) | PTGS2PTGS1 | |
| SCHEMBL6885889 | 0.85 | PTGS2 (0.55) | PTGS2PTGS1ALOX5 | |
| SCHEMBL6885817 | 0.84 | PTGS2 (0.53) | PTGS2PTGS1 | |
| SCHEMBL6877647 | 0.82 | PTGS2 (0.55) | PTGS2PTGS1 | |
| SCHEMBL6884932 | 0.80 | PTGS2 (0.62) | PTGS2PTGS1ALOX5 | |
| SCHEMBL5207846 | 0.80 | PTGS2 (0.62) | PTGS2PTGS1ALOX5 | |
| SCHEMBL6885813 | 0.78 | HSD11B1 (0.51) | PTGS2PTGS1ALOX5 | |
| SCHEMBL5206011 | 0.78 | PTGS2 (0.57) | PTGS2CA2CA4CA7CA1 | |
| SCHEMBL6885382 | 0.78 | CA2 (0.49) | PTGS2CA2CA4CA7CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6803380-B1 | NON-STEROIDAL ANTIINFLAMMATORY DRUGS | LABORATOIRE THERAMEX (MC) | 2004-10-12 | — | — | US | disclosed |
| EP-1246809-B1 | 5-ARYL-1H-1,2,4-TRIAZOLE COMPOUNDS AS INHIBITORS OF CYCLOOXYGENASE-2 AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | THERAMEX (MC) | 2003-07-16 | — | — | EP | disclosed |
| EP-1246809-A1 | 5-ARYL-1H-1,2,4-TRIAZOLE COMPOUNDS AS INHIBITORS OF CYCLOOXYGENASE-2 AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LABORATOIRE THERAMEX (MC) | 2002-10-09 | — | — | EP | disclosed |
| WO-2001034577-A1 | 5-ARYL-1H-1,2,4-TRIAZOLE COMPOUNDS AS INHIBITORS OF CYCLOOXYGENASE-2 AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | LABORATOIRE THERAMEX (MC) | 2001-05-17 | — | — | WO | disclosed |
| EP-1099695-A1 | 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them | LABORATOIRE THERAMEX S.A. (MC) | 2001-05-16 | — | — | EP | disclosed |